Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 43, Issue 2, 2014, Pages 101-108

  Greisen, S R ^a,b   Rasmussen, T K ^a,b   Stengaard Pedersen, K ^b   Hetland, M L ^c,d   Horslev Petersen, K ^e   Hvid, M ^a   Deleuran, B ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; INTERLEUKIN 21; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE COURSE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; PRIORITY JOURNAL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; BETAMETHASONE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYCLOSPORINE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKINS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PEPTIDES, CYCLIC; PROGRAMMED CELL DEATH 1 RECEPTOR; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 84895757227     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.823517     Document Type: Article

References (27)

1. Cope AP, Schulze-Koops H, Aringer M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 2007;25:S4-11
2. Goldring SR, Gravallese EM. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2000;12:195-9
3. Boissier M-C, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009;76:10-14
4. Fife BT, PaukenKE, Eagar TN, Obu T,Wu J, TangQ, et al.Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCRinduced stop signal. Nat Immunol 2009;10:1185-92
5. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al.Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027-34
6. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, et al.The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008;181:6738-46
7. Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FBJ, Coyle AJ, et al.Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol 2006;36:2472-82
8. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008;26:677-704
9. Poholek AC, Hansen K, Hernandez SG, Eto D, Chandele A, Weinstein JS, et al.In vivo regulation of Bcl6 and T follicular helper cell development. J Immunol 2010;185:313-26
10. Yu D, Vinuesa CG. The elusive identity of T follicular helper cells. Trends Immunol 2010;31:377-83
11. McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams MG. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 2009;21:266-73
12. Manivelavan D, C K V. Anti-cyclic citrullinated peptide antibody: An early diagnostic and prognostic biomarker of rheumatoid arthritis. J Clin Diagn Res 2012;6:1393-6
13. Wu H, Miao M, Zhang G, Hu Y, Ming Z, Zhang X. Soluble PD-1 is associated with aberrant regulation of T cells activation in aplastic anemia. Immunol Invest 2009;38:408-21
14. Wan B, Nie H, Liu A, Feng G, He D, Xu R, et al.Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 2006;177:8844-50
15. Song M-Y, Park S-H, Nam HJ, Choi D-H, Sung Y-C. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1. J Immunother 2011;34:297-306
16. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, et al.Combination treatment with metho trexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54:1401-9
17. Hetland ML, Stengaard-Pedersen K, Junker P, Østergaard M, Ejbjerg BJ, Jacobsen S, et al. Radiographic progression and remission rates in early rheumatoid arthritis -MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis 2010;69:1789-95
18. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K, et al.Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 2010;37:2014-20
19. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012;209: 1241-53
20. Gowthaman U, Chodisetti SB, Agrewala JN. T cell help to B cells in germinal centers: Putting the jigsaw together. Int Rev Immunol 2010;29:403-20
21. Wang G, Hu P, Yang J, Shen G, Wu X. The effects of PDL-Ig on collagen-induced arthritis. Rheumatol Int 2009;31:513-19
22. Nielsen C, Ohm-Laursen L, Barington T, Husby S, Lillevang ST. Alternative splice variants of the human PD-1 gene. Cell Immunol 2005;235:109-16
23. Kerlan-Candon S, Louis-Plence P, Wiedemann A, Combe B, Clot J, Eliaou JF, et al.Specific overexpression of rheumatoid arthritisassociated HLA-DR alleles and presentation of low-Affinity peptides. Arthritis Rheum 2001;44:1281-92
24. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-9
25. Nakashima T, Takayanagi H. Osteoclasts and the immune system. J Bone Miner Metab 2009;27:519-29
26. Axmann R, Herman S, Zaiss M, Franz S, Polzer K, Zwerina J, et al. CTLA-4 directly inhibits osteoclast formation. Ann Rheum Dis 2008;67:1603-9
27. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al.Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009;6:e1